Xingaotopi

China
Qigong, Guangdong, China

Company profile

Xingaotopi company profile

Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies.

Business identity

Contact email
[email protected]
Phone number
+86 021-33670678
Operating status
Active
Company type
For Profit
Founded
2022-01-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$14.3M
Last funding
Seed / $14.3M / 2026-01-04
Last equity funding
Seed / $14.3M
Investors
4

Founders and investors

Investors

Dingxin CapitalNanjing Innovation Capital GroupNanjing Xingang High InvestmentRehab Capital New Drug Fund